Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Synthesis, α-glycosidase inhibitory potential and molecular docking study of benzimidazole derivatives.

Taha M, Rahim F, Zaman K, Selvaraj M, Uddin N, Farooq RK, Nawaz M, Sajid M, Nawaz F, Ibrahim M, Khan KM.

Bioorg Chem. 2020 Jan;95:103555. doi: 10.1016/j.bioorg.2019.103555. Epub 2019 Dec 26.

PMID:
31911306
2.

Synthesis, anti-leishmanial and molecular docking study of bis-indole derivatives.

Taha M, Uddin I, Gollapalli M, Almandil NB, Rahim F, Farooq RK, Nawaz M, Ibrahim M, Alqahtani MA, Bamarouf YA, Selvaraj M.

BMC Chem. 2019 Aug 6;13(1):102. doi: 10.1186/s13065-019-0617-4. eCollection 2019 Dec.

3.

Exposure to early life adversity alters the future behavioral response to a stressful challenge in BALB/C mice.

Nisar S, Farooq RK, Nazir S, Alamoudi W, Alhibshi A.

Physiol Behav. 2019 Oct 15;210:112622. doi: 10.1016/j.physbeh.2019.112622. Epub 2019 Jul 17.

PMID:
31325513
4.

Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent β-Glucuronidase Inhibitors.

Taha M, Rahim F, Ali M, Khan MN, Alqahtani MA, Bamarouf YA, Gollapalli M, Farooq RK, Shah SAA, Ahmed QU, Zakaria ZA.

Molecules. 2019 Apr 18;24(8). pii: E1528. doi: 10.3390/molecules24081528.

5.

Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.

Almandil NB, Taha M, Farooq RK, Alhibshi A, Ibrahim M, Anouar EH, Gollapalli M, Rahim F, Nawaz M, Shah SAA, Ahmed QU, Zakaria ZA.

Molecules. 2019 Mar 13;24(6). pii: E1002. doi: 10.3390/molecules24061002.

6.

Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.

Anouar EH, Moustapha ME, Taha M, Geesi MH, Farag ZR, Rahim F, Almandil NB, Farooq RK, Nawaz M, Mosaddik A.

Molecules. 2019 Mar 8;24(5). pii: E963. doi: 10.3390/molecules24050963.

7.

A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice.

Farooq RK, Tanti A, Ainouche S, Roger S, Belzung C, Camus V.

Psychoneuroendocrinology. 2018 Nov;97:120-130. doi: 10.1016/j.psyneuen.2018.07.016. Epub 2018 Jul 10.

PMID:
30015007
8.

Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase.

Javid MT, Rahim F, Taha M, Nawaz M, Wadood A, Ali M, Mosaddik A, Shah SAA, Farooq RK.

Bioorg Chem. 2018 Sep;79:323-333. doi: 10.1016/j.bioorg.2018.05.011. Epub 2018 May 17.

PMID:
29803079
9.

Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.

Ullah H, Rahim F, Taha M, Uddin I, Wadood A, Shah SAA, Farooq RK, Nawaz M, Wahab Z, Khan KM.

Bioorg Chem. 2018 Aug;78:58-67. doi: 10.1016/j.bioorg.2018.02.020. Epub 2018 Mar 7.

PMID:
29533215
10.

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors.

Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K.

Onco Targets Ther. 2017 Jan 21;10:463-476. doi: 10.2147/OTT.S119362. eCollection 2017. Review.

11.

Role of inflammatory cytokines in depression: Focus on interleukin-1β.

Farooq RK, Asghar K, Kanwal S, Zulqernain A.

Biomed Rep. 2017 Jan;6(1):15-20. doi: 10.3892/br.2016.807. Epub 2016 Nov 10.

12.

Dysregulation of the hypothalamus-pituitary-adrenal axis predicts some aspects of the behavioral response to chronic fluoxetine: association with hippocampal cell proliferation.

Khemissi W, Farooq RK, Le Guisquet AM, Sakly M, Belzung C.

Front Behav Neurosci. 2014 Sep 30;8:340. doi: 10.3389/fnbeh.2014.00340. eCollection 2014.

13.

Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?

Farooq RK, Isingrini E, Tanti A, Le Guisquet AM, Arlicot N, Minier F, Leman S, Chalon S, Belzung C, Camus V.

Behav Brain Res. 2012 May 16;231(1):130-7. doi: 10.1016/j.bbr.2012.03.020. Epub 2012 Mar 20.

PMID:
22465167

Supplemental Content

Loading ...
Support Center